PAM-flexible genome editing with an engineered chimeric Cas9

被引:17
|
作者
Zhao, Lin [1 ]
Koseki, Sabrina R. T. [1 ]
Silverstein, Rachel A. [2 ,3 ,4 ]
Amrani, Nadia [5 ]
Peng, Christina [6 ]
Kramme, Christian [7 ]
Savic, Natasha [6 ]
Pacesa, Martin [8 ]
Rodriguez, Tomas C. [5 ]
Stan, Teodora [1 ]
Tysinger, Emma [1 ]
Hong, Lauren [1 ]
Yudistyra, Vivian [1 ]
Ponnapati, Manvitha R. [9 ]
Jacobson, Joseph M. [9 ]
Church, George M. [7 ]
Jakimo, Noah [9 ]
Truant, Ray [6 ]
Jinek, Martin [8 ]
Kleinstiver, Benjamin P. [2 ,3 ,10 ]
Sontheimer, Erik J. [5 ]
Chatterjee, Pranam [1 ,11 ]
机构
[1] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA
[2] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[4] Harvard Univ, Biol & Biomed Sci Program, Boston, MA USA
[5] Univ Massachusetts, RNA Therapeut Inst, Sch Med, Cambridge, MA USA
[6] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada
[7] Harvard Univ, Wyss Inst Biolog Inspired Engn, Cambridge, MA USA
[8] Univ Zurich, Dept Biochem, Zurich, Switzerland
[9] MIT, Media Lab, Cambridge, MA USA
[10] Harvard Med Sch, Dept Pathol, Boston, MA USA
[11] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA
基金
美国国家卫生研究院; 加拿大自然科学与工程研究理事会; 瑞士国家科学基金会;
关键词
CRISPR-CAS9; NUCLEASES; DNA; ENDONUCLEASE; BASE; RECOGNITION; VARIANTS;
D O I
10.1038/s41467-023-41829-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CRISPR enzymes require a defined protospacer adjacent motif (PAM) flanking a guide RNA-programmed target site, limiting their sequence accessibility for robust genome editing applications. In this study, we recombine the PAM-interacting domain of SpRY, a broad-targeting Cas9 possessing an NRN > NYN (R = A or G, Y = C or T) PAM preference, with the N-terminus of Sc + +, a Cas9 with simultaneously broad, efficient, and accurate NNG editing capabilities, to generate a chimeric enzyme with highly flexible PAM preference: SpRYc. We demonstrate that SpRYc leverages properties of both enzymes to specifically edit diverse PAMs and disease-related loci for potential therapeutic applications. In total, the approaches to generate SpRYc, coupled with its robust flexibility, highlight the power of integrative protein design for Cas9 engineering and motivate downstream editing applications that require precise genomic positioning.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [42] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [43] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [44] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [46] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [47] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [48] Enhanced genome editing with a Streptococcus equinus Cas9
    Liu, Jingtong
    Wang, Yao
    Wei, Jingjing
    Wang, Shengzhou
    Li, Miaomiao
    Huang, Zheyong
    Zhang, Sufang
    Liu, Huihui
    Huang, Jinhai
    Wang, Yongming
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [49] CRISPR/Cas9 editing of the genome for cancer modeling
    Guernet, Alexis
    Grumolato, Luca
    METHODS, 2017, 121 : 130 - 137
  • [50] Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
    Brett T Staahl
    Madhurima Benekareddy
    Claire Coulon-Bainier
    Ashwin A Banfal
    Stephen N Floor
    Jennifer K Sabo
    Cole Urnes
    Gabriela Acevedo Munares
    Anirvan Ghosh
    Jennifer A Doudna
    Nature Biotechnology, 2017, 35 : 431 - 434